|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 面向21世纪的卒中新定义:美国心脏病学会和美国卒中学会声明显示文摘尽管脑血管病有着全球性影响且对其病理生理学的认识有了很多进步,但是'卒中'这一术语在临床实践、临床研究或公共卫生评估中的定义却不一致。传统的定义依据于临床,却没有考虑到科学技术的进步。美国心脏协会(AHA)和美国卒中协会(ASA)卒中分会组织了写作小组,为21世纪卒中新定义撰写专家共识性声明。中枢神经系统(CNS)梗死,指由缺血所导致的脑、脊髓或视网膜的细胞死亡,是基于持续性损害的神经病理学、神经影像学和(或)临床证据。CNS梗死表现为一个临床谱:缺血性卒中特指伴有明显症状的CNS梗死,而静息性梗死根据定义指未引起已知的症状的梗死。卒中也还包括脑出血和蛛网膜下腔出血。新定义的卒中结合了临床和组织学标准,可被用于实践、研究和公共卫生评估。 | 俞羚 董荃 宋叶平 江静雯 李卉 刘亮贤 苏爱萍 李焰生 Sacco RL Kasner SE Broderick JP Caplan LR Connors JJ Culebras A Elkind MS George MG Hamdan AD Higashida RT Hoh BL Janis LS Kase CS Kleindorfer DO Lee JM Moseley ME Peterson ED Turan TN Valderrama AL Vinters HV | 2013 | 神经病学与神经康复学杂志2013，10，2： | 188 |
| 2 | 稳定性冠状动脉疾病患者的尿11-脱氢血栓素B_2与死亡率的关系显示文摘已有研究证明,应用阿司匹林抗血小板治疗可减少冠状动脉疾病(coronary artery disease,CAD)患者的不良预后。阿司匹林不可逆地抑制血小板环加氧酶1(cyclooxygenase-1,COX-1)并减弱血栓烷A2(thromboxane A2,TXA2)介导的血小板聚集, | 刘莉 叶鹏 McCullough PA Vasudevan A Sathyamoorthy M Schussler JM Velasco CE Lopez LR Swift C Peterson M Bennett-Firmin J Schiffmann R Bottiglieri T | 2017 | 中华高血压杂志2017，25，1： | 3 |
| 3 | Quinolone molecular structure-activity relationships:what we have learned about improving antimicrobial activity显示文摘 | Peterson LR | 2001 | Clin Infect Dis2001，33，3： | 1 |
| 4 | Fungal meningitis manifesting as hydrocephalus显示文摘 | Mangham D Gerding DN Peterson LR | 1983 | Arch Intern Med1983，143，4： | 1 |
| 5 | Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women显示文摘 | Peterson LR Herrero P Schechtman KB | 2004 | Circulation2004，109，18： | 1 |
| 6 | Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B 显示文摘 | Demakos EP Peterson BL | 2002 | J Clin Oncol2002，20，10： | 1 |
| 7 | Squeezing the antibiotic balloon:the impact of antimicrobial classes on emerging resistance 显示文摘 | Peterson LR | 2005 | Clin Microbiol Infect2005，11，5： | 1 |
| 8 | New technology for detecting mul- tidrug-resistantpathogens in the clinical microbiology laborato- ry显示文摘 | Peterson LR Noskin GA | 2001 | Eme-rg Infect Dis2001，7，2： | 1 |
| 9 | Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance显示文摘 | Peterson LR | 2005 | Clin Microbiol Infect2005，11，5： | 1 |
| 10 | Increased myocardial fat ty acid metabolism in patients with type 1 diabetes mellitus显示文摘 | Herrero P Peterson LR McGill JB | 2006 | Am Coil Cardiol2006，47，3： | 1 |
| 11 | Ciprofloxacin resistance in coagulase-positive and-negative staphylococci: role of mutations at serine 84 in DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis 显示文摘 | Sreedharan S Peterson LR Fisher LM | 1991 | Antimicrob Agents Chemother1991，35，10： | 1 |
| 12 | Comparison of effects of exercise and diuretic on left ventricular geometry,mass,and insulin resistance in older hypertensive adults显示文摘 | Rinder MR Spina RJ Peterson LR | | 0，，： | 1 |
| 13 | Response rates in patients with acute myeloid leukemia,treated with azacytidine,using WHO and intenrational working group criteria for myelodysplastic syndrome显示文摘 | Silverman LR McKenzie DR Peterson BL | 2005 | Blood2005，106，： | 1 |
| 14 | Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance显示文摘 | Peterson LR | 2005 | Clin Microbiol Infect2005，11，5： | 1 |
| 15 | Chromogenic media versus Real-Time PCR for nasal surveillance of methicillin-resistant Staphylococcus aureus:impact on detection of MRSA-positive persons显示文摘 | Paule S M Mehta M Robicsek A Gonzalzles TM Robicsek A Peterson LR | | American Journal of Clinical Pathology0，，： | 1 |
| 16 | Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome:a study of the cancer and leukemia group B显示文摘 | Silverman LR Demakos EP Peterson BL | 2002 | J Clin Oncol2002，20，： | 1 |
| 17 | Response rates in patients with acute myeloid leukemia, treated with azacytidine, using WHO and intenrational working group criteria for myelodysplastic syndrome 显示文摘 | Silverman LR McKenzie DR Peterson BL | 2005 | Blood2005，106，： | 1 |
| 18 | Further analysis of trials with azacitidine in patients with myelodysplastic syndrome:studies 8421,8921,and 9221 by the Cancer and Leukemia Group B显示文摘 | Silverman LR McKenzie DR Peterson BL | 2006 | J Clin Oncol2006，24，： | 1 |
| 19 | Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B 显示文摘 | Silverman LR Demakos EP Peterson BL | 2002 | J Clin Oncol2002，20，： | 1 |
| 20 | Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421,8921, and 9221 by the Cancer and Leukemia Group B 显示文摘 | Silverman LR McKenzie DR Peterson BL | 2006 | J Clin Oncol2006，24，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员